Loading the security overview…
Where the tokens are
What CRISPR Therapeutics has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Aug 3, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Aug 3, 2026 | 8-K | Current report | On SEC.gov |
| Jun 4, 2026 | 8-K | Current report | On SEC.gov |
| May 4, 2026 | 10-Q | Quarterly report | On SEC.gov |
| May 4, 2026 | 8-K | Current report | On SEC.gov |
| Mar 16, 2026 | 8-K | Current report | On SEC.gov |
| Mar 11, 2026 | 8-K | Current report | On SEC.gov |
| Feb 12, 2026 | 10-K | Annual report | On SEC.gov |
| Feb 12, 2026 | 8-K | Current report | On SEC.gov |
| Jan 12, 2026 | 8-K | Current report | On SEC.gov |
| Nov 10, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Nov 10, 2025 | 8-K | Current report | On SEC.gov |
| Oct 15, 2025 | 8-K | Current report | On SEC.gov |
| Aug 4, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Aug 4, 2025 | 8-K | Current report | On SEC.gov |
| Jun 26, 2025 | 8-K | Current report | On SEC.gov |
| Jun 9, 2025 | 8-K | Current report | On SEC.gov |
| May 19, 2025 | 8-K | Current report | On SEC.gov |
| May 6, 2025 | 10-Q | Quarterly report | On SEC.gov |
| May 6, 2025 | 8-K | Current report | On SEC.gov |
| Mar 26, 2025 | 8-K | Current report | On SEC.gov |
| Feb 11, 2025 | 10-K | Annual report | On SEC.gov |
| Feb 11, 2025 | 8-K | Current report | On SEC.gov |
| Nov 5, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Nov 5, 2024 | 8-K | Current report | On SEC.gov |
| Aug 5, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Aug 5, 2024 | 8-K | Current report | On SEC.gov |
| Jun 3, 2024 | 8-K | Current report | On SEC.gov |
| May 23, 2024 | 8-K | Current report | On SEC.gov |
| May 8, 2024 | 10-Q | Quarterly report | On SEC.gov |
| May 8, 2024 | 8-K | Current report | On SEC.gov |
| Feb 21, 2024 | 10-K | Annual report | On SEC.gov |
| Feb 21, 2024 | 8-K | Current report | On SEC.gov |
| Feb 13, 2024 | 8-K | Current report | On SEC.gov |
| Feb 13, 2024 | 8-K | Current report | On SEC.gov |
| Jan 16, 2024 | 8-K | Current report | On SEC.gov |
| Dec 19, 2023 | 8-K | Current report | On SEC.gov |
| Dec 15, 2023 | 8-K | Current report | On SEC.gov |
| Dec 13, 2023 | 8-K | Current report | On SEC.gov |
| Dec 8, 2023 | 8-K | Current report | On SEC.gov |
| Dec 4, 2023 | 8-K | Current report | On SEC.gov |
| Nov 16, 2023 | 8-K | Current report | On SEC.gov |
| Nov 6, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Nov 6, 2023 | 8-K | Current report | On SEC.gov |
| Sep 7, 2023 | 8-K | Current report | On SEC.gov |
| Aug 7, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Aug 7, 2023 | 8-K | Current report | On SEC.gov |
| Jun 9, 2023 | 8-K | Current report | On SEC.gov |
| Jun 9, 2023 | 8-K | Current report | On SEC.gov |
| May 8, 2023 | 10-Q | Quarterly report | On SEC.gov |
| May 8, 2023 | 8-K | Current report | On SEC.gov |
| Apr 3, 2023 | 8-K | Current report | On SEC.gov |
| Mar 29, 2023 | 8-K | Current report | On SEC.gov |
| Mar 27, 2023 | 8-K | Current report | On SEC.gov |
| Mar 14, 2023 | 8-K | Current report | On SEC.gov |
| Feb 21, 2023 | 10-K | Annual report | On SEC.gov |
| Feb 21, 2023 | 8-K | Current report | On SEC.gov |
| Nov 1, 2022 | 10-Q | Quarterly report | On SEC.gov |
| Nov 1, 2022 | 8-K | Current report | On SEC.gov |
| Oct 27, 2022 | 8-K | Current report | On SEC.gov |
Figures describe CRISPR Therapeutics shares, not any token. As of Sep 24, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.